| BSE: 500091 | Sector: Health care |
| NSE: COREPARENT | ISIN Code: INE494A01017 |
| BSE 05:30 | 01 Jan | Core Healthcare Ltd |
| NSE 05:30 | 01 Jan | Core Healthcare Ltd |
11.08 am | 15 Jul 2018 | Business Standard
BS ReporterHyderabad, 14 July: Aurobindo Pharma Limited announced today that its step-down subsidiary Agile Pharma B V(Netherlands ) signed a definiti...
9.15 pm | 14 Jul 2018 | Business Standard
With sales of around $1.86 billion annually, Suboxone was one of the key near-term launches lined up by Dr Reddy's this year
1.45 am | 14 Jul 2018 | Business Standard
Outbids TPG-Manipal combine, will invest Rs 40 bn at Rs 170 a share through preferential allotment
12.07 am | 14 Jul 2018 | Business Standard
The brothers, however, did not comment on issues around the Fortis brand
6.24 am | 13 Jul 2018 | Business Standard
The possible acquisition will allow the IHH to expand its footprint across the country
2.11 am | 13 Jul 2018 | Business Standard
Firm says it is disappointed with the outcome of the inspection
1.09 pm | 12 Jul 2018 | Press Trust of India
The product has been developed by Swiss pharma group, Helsinn and Glenmark has exclusive marketing rights for it in India and Nepal
11.49 pm | 11 Jul 2018 | Business Standard
Street cautious as Mallinckrodt biz is declining amid enhanced scrutiny on opioid drugs
1.28 pm | 11 Jul 2018 | Press Trust of India
The two drugs, Gibtulio Met and Ajaduo, will be co-marketed simultaneously by Boehringer Ingelheim and Lupin across India under different brand names
1.05 pm | 11 Jul 2018 | Press Trust of India
The tablets are available in 200 mg in the bottle count sizes of 100 and 500
10.21 am | 11 Jul 2018 | Business Standard
The stock surged 13% to Rs 434 on the BSE in morning trade after the company said it has received EIR from the US health regulator for it's both facil...
11.09 am | 10 Jul 2018 | Bloomberg
Before any new ailments are diagnosed for the auditor to have to change that opinion, the patient needs to find new caregivers
6.37 pm | 9 Jul 2018 | Business Standard
Briviact is approved as an adjunctive therapy for the treatment of partial-onset seizures in epilepsy patients who are 16 years of age and older
3.15 pm | 9 Jul 2018 | Business Standard
At 02:30 PM; the S&P BSE Sensex was up 308 points at 35,966, rallied 1,063 points or 3% from 34,903 levels on June 5, 2018.
1.47 am | 8 Jul 2018 | Business Standard
The Fortis board had commissioned law firm Luthra & Luthra to look into alleged financial irregularities
11.38 am | 6 Jul 2018 | Business Standard
Its two research arms have achieved path-breaking outcomes in non-invasive, cost-effective cancer bio-markers
2.17 am | 6 Jul 2018 | Business Standard
Participation Finance took RHC Holding-the promoter group holding company-along with Fortis and other related parties to the court
12.27 pm | 4 Jul 2018 | Press Trust of India
These patents are valid through 2031, 2034, 2034 and 2036 respectively, the company said in a BSE filing
12.20 pm | 4 Jul 2018 | Business Standard
In past one month, Lupin has outperformed the market by surging 23% as compared to 1.4% rise in the S&P BSE Sensex.
11.27 am | 4 Jul 2018 | Business Standard
Midcaps stocks have under-performed their large-cap peers so far in calendar year 2018 (CY18)
